nodes	percent_of_prediction	percent_of_DWPC	metapath
Posaconazole—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.286	0.625	CbGbCtD
Posaconazole—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.171	0.375	CbGbCtD
Posaconazole—Vestibular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0204	0.0376	CcSEcCtD
Posaconazole—Haemolytic uraemic syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.0188	0.0346	CcSEcCtD
Posaconazole—Thrombotic thrombocytopenic purpura—Cyclosporine—focal segmental glomerulosclerosis	0.0143	0.0264	CcSEcCtD
Posaconazole—Traumatic liver injury—Cyclosporine—focal segmental glomerulosclerosis	0.011	0.0203	CcSEcCtD
Posaconazole—Trauma—Cyclosporine—focal segmental glomerulosclerosis	0.00861	0.0159	CcSEcCtD
Posaconazole—Night sweats—Cyclosporine—focal segmental glomerulosclerosis	0.0076	0.014	CcSEcCtD
Posaconazole—Urine abnormality—Cyclosporine—focal segmental glomerulosclerosis	0.00741	0.0136	CcSEcCtD
Posaconazole—Hypertriglyceridaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00714	0.0131	CcSEcCtD
Posaconazole—Urine analysis abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00697	0.0128	CcSEcCtD
Posaconazole—Cerebration impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00697	0.0128	CcSEcCtD
Posaconazole—Hypomagnesaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00645	0.0119	CcSEcCtD
Posaconazole—Encephalopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00639	0.0118	CcSEcCtD
Posaconazole—Blood triglycerides increased—Cyclosporine—focal segmental glomerulosclerosis	0.00626	0.0115	CcSEcCtD
Posaconazole—Menstrual disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00602	0.0111	CcSEcCtD
Posaconazole—Interstitial lung disease—Cyclosporine—focal segmental glomerulosclerosis	0.00579	0.0107	CcSEcCtD
Posaconazole—Influenza-like symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00574	0.0106	CcSEcCtD
Posaconazole—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00569	0.0105	CcSEcCtD
Posaconazole—Tongue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00564	0.0104	CcSEcCtD
Posaconazole—Cholestasis—Cyclosporine—focal segmental glomerulosclerosis	0.0054	0.00994	CcSEcCtD
Posaconazole—Coagulopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00527	0.00969	CcSEcCtD
Posaconazole—Gingivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00522	0.00962	CcSEcCtD
Posaconazole—Rigors—Cyclosporine—focal segmental glomerulosclerosis	0.00502	0.00924	CcSEcCtD
Posaconazole—Liver injury—Cyclosporine—focal segmental glomerulosclerosis	0.00487	0.00897	CcSEcCtD
Posaconazole—Neoplasm malignant—Cyclosporine—focal segmental glomerulosclerosis	0.0048	0.00884	CcSEcCtD
Posaconazole—Disturbance in attention—Cyclosporine—focal segmental glomerulosclerosis	0.00473	0.00871	CcSEcCtD
Posaconazole—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.0047	0.00865	CcSEcCtD
Posaconazole—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00467	0.00859	CcSEcCtD
Posaconazole—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00457	0.00841	CcSEcCtD
Posaconazole—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00451	0.0083	CcSEcCtD
Posaconazole—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.00451	0.0083	CcSEcCtD
Posaconazole—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.00445	0.00819	CcSEcCtD
Posaconazole—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.00445	0.00819	CcSEcCtD
Posaconazole—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00442	0.00814	CcSEcCtD
Posaconazole—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.00442	0.00814	CcSEcCtD
Posaconazole—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00431	0.00793	CcSEcCtD
Posaconazole—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.00418	0.00769	CcSEcCtD
Posaconazole—Hepatocellular injury—Cyclosporine—focal segmental glomerulosclerosis	0.0041	0.00755	CcSEcCtD
Posaconazole—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.0041	0.00755	CcSEcCtD
Posaconazole—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00403	0.00742	CcSEcCtD
Posaconazole—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.00403	0.00742	CcSEcCtD
Posaconazole—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.00398	0.00733	CcSEcCtD
Posaconazole—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.00396	0.00729	CcSEcCtD
Posaconazole—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.00391	0.00721	CcSEcCtD
Posaconazole—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.00389	0.00717	CcSEcCtD
Posaconazole—Blood urea increased—Cyclosporine—focal segmental glomerulosclerosis	0.00387	0.00713	CcSEcCtD
Posaconazole—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00385	0.00709	CcSEcCtD
Posaconazole—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.00375	0.0069	CcSEcCtD
Posaconazole—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.00371	0.00682	CcSEcCtD
Posaconazole—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.00356	0.00655	CcSEcCtD
Posaconazole—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.00356	0.00655	CcSEcCtD
Posaconazole—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00349	0.00642	CcSEcCtD
Posaconazole—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00341	0.00627	CcSEcCtD
Posaconazole—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.00336	0.00618	CcSEcCtD
Posaconazole—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00333	0.00612	CcSEcCtD
Posaconazole—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.00333	0.00612	CcSEcCtD
Posaconazole—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.00331	0.0061	CcSEcCtD
Posaconazole—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.0033	0.00607	CcSEcCtD
Posaconazole—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.00324	0.00596	CcSEcCtD
Posaconazole—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00321	0.00591	CcSEcCtD
Posaconazole—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00318	0.00586	CcSEcCtD
Posaconazole—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00317	0.00583	CcSEcCtD
Posaconazole—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00315	0.00581	CcSEcCtD
Posaconazole—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00313	0.00576	CcSEcCtD
Posaconazole—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00309	0.00568	CcSEcCtD
Posaconazole—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00305	0.00561	CcSEcCtD
Posaconazole—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00295	0.00544	CcSEcCtD
Posaconazole—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00293	0.00539	CcSEcCtD
Posaconazole—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00293	0.00539	CcSEcCtD
Posaconazole—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00282	0.00519	CcSEcCtD
Posaconazole—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00279	0.00513	CcSEcCtD
Posaconazole—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00273	0.00502	CcSEcCtD
Posaconazole—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00272	0.005	CcSEcCtD
Posaconazole—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00269	0.00495	CcSEcCtD
Posaconazole—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00268	0.00493	CcSEcCtD
Posaconazole—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00263	0.00485	CcSEcCtD
Posaconazole—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00263	0.00483	CcSEcCtD
Posaconazole—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00259	0.00477	CcSEcCtD
Posaconazole—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00257	0.00474	CcSEcCtD
Posaconazole—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00252	0.00464	CcSEcCtD
Posaconazole—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00251	0.00461	CcSEcCtD
Posaconazole—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00241	0.00443	CcSEcCtD
Posaconazole—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00239	0.0044	CcSEcCtD
Posaconazole—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00238	0.00437	CcSEcCtD
Posaconazole—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00234	0.00431	CcSEcCtD
Posaconazole—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00233	0.00428	CcSEcCtD
Posaconazole—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00232	0.00427	CcSEcCtD
Posaconazole—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00231	0.00425	CcSEcCtD
Posaconazole—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00229	0.00422	CcSEcCtD
Posaconazole—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00229	0.00422	CcSEcCtD
Posaconazole—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00226	0.00416	CcSEcCtD
Posaconazole—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.00225	0.00415	CcSEcCtD
Posaconazole—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00225	0.00414	CcSEcCtD
Posaconazole—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00225	0.00414	CcSEcCtD
Posaconazole—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00224	0.00412	CcSEcCtD
Posaconazole—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00224	0.00412	CcSEcCtD
Posaconazole—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.0041	CcSEcCtD
Posaconazole—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.0041	CcSEcCtD
Posaconazole—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00219	0.00403	CcSEcCtD
Posaconazole—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00217	0.00399	CcSEcCtD
Posaconazole—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00216	0.00398	CcSEcCtD
Posaconazole—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00215	0.00396	CcSEcCtD
Posaconazole—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00207	0.00381	CcSEcCtD
Posaconazole—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00206	0.0038	CcSEcCtD
Posaconazole—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00206	0.00379	CcSEcCtD
Posaconazole—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00206	0.00379	CcSEcCtD
Posaconazole—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00205	0.00377	CcSEcCtD
Posaconazole—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00204	0.00376	CcSEcCtD
Posaconazole—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00203	0.00374	CcSEcCtD
Posaconazole—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00202	0.00372	CcSEcCtD
Posaconazole—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00202	0.00372	CcSEcCtD
Posaconazole—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00192	0.00353	CcSEcCtD
Posaconazole—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00191	0.00352	CcSEcCtD
Posaconazole—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00187	0.00344	CcSEcCtD
Posaconazole—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00186	0.00342	CcSEcCtD
Posaconazole—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00185	0.0034	CcSEcCtD
Posaconazole—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00184	0.00339	CcSEcCtD
Posaconazole—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00182	0.00335	CcSEcCtD
Posaconazole—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0018	0.00332	CcSEcCtD
Posaconazole—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00179	0.0033	CcSEcCtD
Posaconazole—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.00325	CcSEcCtD
Posaconazole—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00176	0.00323	CcSEcCtD
Posaconazole—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00172	0.00317	CcSEcCtD
Posaconazole—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00169	0.00311	CcSEcCtD
Posaconazole—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00168	0.00309	CcSEcCtD
Posaconazole—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00166	0.00306	CcSEcCtD
Posaconazole—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00166	0.00305	CcSEcCtD
Posaconazole—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.00303	CcSEcCtD
Posaconazole—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00162	0.00298	CcSEcCtD
Posaconazole—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.00296	CcSEcCtD
Posaconazole—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.00295	CcSEcCtD
Posaconazole—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00156	0.00288	CcSEcCtD
Posaconazole—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00155	0.00286	CcSEcCtD
Posaconazole—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00155	0.00285	CcSEcCtD
Posaconazole—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.00281	CcSEcCtD
Posaconazole—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.00281	CcSEcCtD
Posaconazole—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.00281	CcSEcCtD
Posaconazole—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00152	0.0028	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00152	0.00279	CcSEcCtD
Posaconazole—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00151	0.00278	CcSEcCtD
Posaconazole—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00149	0.00275	CcSEcCtD
Posaconazole—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.00272	CcSEcCtD
Posaconazole—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.00269	CcSEcCtD
Posaconazole—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00145	0.00268	CcSEcCtD
Posaconazole—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.00264	CcSEcCtD
Posaconazole—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.00264	CcSEcCtD
Posaconazole—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.00262	CcSEcCtD
Posaconazole—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.0026	CcSEcCtD
Posaconazole—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.00257	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.00245	CcSEcCtD
Posaconazole—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.00244	CcSEcCtD
Posaconazole—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00131	0.00242	CcSEcCtD
Posaconazole—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.0013	0.0024	CcSEcCtD
Posaconazole—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.0013	0.00239	CcSEcCtD
Posaconazole—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.00237	CcSEcCtD
Posaconazole—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.00234	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.00232	CcSEcCtD
Posaconazole—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.00232	CcSEcCtD
Posaconazole—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00125	0.0023	CcSEcCtD
Posaconazole—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00125	0.0023	CcSEcCtD
Posaconazole—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.00222	CcSEcCtD
Posaconazole—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.0022	CcSEcCtD
Posaconazole—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.00214	CcSEcCtD
Posaconazole—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.00213	CcSEcCtD
Posaconazole—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.00213	CcSEcCtD
Posaconazole—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00198	CcSEcCtD
Posaconazole—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.00193	CcSEcCtD
Posaconazole—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.00191	CcSEcCtD
Posaconazole—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.001	0.00184	CcSEcCtD
Posaconazole—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000967	0.00178	CcSEcCtD
Posaconazole—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00093	0.00171	CcSEcCtD
Posaconazole—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000922	0.0017	CcSEcCtD
Posaconazole—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000922	0.0017	CcSEcCtD
Posaconazole—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000916	0.00169	CcSEcCtD
Posaconazole—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000869	0.0016	CcSEcCtD
